In addition to pulling funds from Planned Parenthood, The Susan G. Komen Foundation also decided to stop funding embryonic stem cell research centers, making it fully transparent the organization has evolved from non-political non-profit to a partisan advocacy organization.
That means the loss of $3.75 million to the Johns Hopkins University School of Medicine, $4.5 million to the University of Kansas Medical Center, $1 million to the U.S. National Cancer Institute, $1 million to the Society for Women’s Health Research, and $600,000 to Yale University. That’s a loss of nearly $12 million dollars in research money to eradicate breast cancer this year alone.
This is a new position for the organization which had previously supported all sorts of scientific research targeted at finding a cure for breast cancer and saving women’s lives. Its new position is that the organization will categorically no longer support any embryonic stem cell research.
Instead of the loud, clumsy announcement Komen made in severing ties with Planned Parenthood, this is a decision they quietly slipped in during November 2011. After all, with this new pro-life branding, you would think the Susan G. Komen Foundation would want to crow about its policy change since embryonic stem cell research is an issue near and dear to the anti-choice crowd Komen now serves.
Maybe it’s because there won’t be any gory anti-stem cell research ad running during the Super Bowl this Sunday like Randall Terry’s anti-abortion ad. After all, Karen Handel has made it clear she and Terry share an agenda, and the Komen Foundation has under Handel’s watch closely allied itself with Americans United For Life, the zealously anti-choice group that takes credit for pushing Komen directly and through members of Congress, to sever ties with Planned Parenthood.
Could it be that the Komen decision was timed in part to help flood the media with a barrage of anti-abortion attacks, airing primarily in key swing states in the 2012 election?
Well, let me ask this. What else could explain the stark contrast in the way Komen released information about these decisions?
Photo from guisse95 via flickr.
Disclaimer: The views expressed above are solely those of the author and may
not reflect those of
Care2, Inc., its employees or advertisers.